Drug Company

Feb 12, 2016 at 21:33 | Source: Moneycontrol.com
Kilitch Drugs India in its meeting held on February 12, 2016, has adopted the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and authorised Mr. Mukund Mehta, Managing Director of the Company to sign, enter and execute the amended Listing Agreement under said Regulations and the same shall be forwarded to BSE & NSE.
Feb 12, 2016 at 21:32 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals at its meeting held on February 12, 2016, has considered and approved postal ballot for change of Name and objects of the Company and in the process has appointed scrutinizer and finalized the calendar of events for postal ballot.
Feb 12, 2016 at 21:18 | Source: PTI
The significant violations included the company's failure "to maintain floors, walls, and ceilings of smooth, hard surfaces that are easily cleanable in aseptic processing areas".
Feb 11, 2016 at 10:36 | Source: Moneycontrol.com
The company has received compliance letter for both API manufacturing sites located at Deosugur Industrial Area, Deosugur and Raichur Industrial Growth Centre, Chicksugur, Raichur, Karnataka, India.
Feb 09, 2016 at 17:30 | Source: PTI
The company expects to notch a global turnover of Rs 100 crore from this bulk drug alone in 2016-17.
Feb 08, 2016 at 11:30 | Source: PTI
The company added the commercial launch of the product is planned for the coming quarter.
Feb 08, 2016 at 08:53 | Source: PTI
The Mumbai-based company has included its two drugs -- Abirapro prescribed for prostate cancer and Evermil, indicated for different cancers, such as breast and renal cell carcinoma -- under the scheme. Currently, Abirapro 250 mg in 120 pack size is priced at Rs 39,990.
Feb 05, 2016 at 17:44 | Source: Moneycontrol.com
BofA ML, in a report titled Media news: US making API mfg mandatory locally for Govt. supplies; minimal impact, says that while the main motive behind the move is to promote API industry, it could directly impact the core companies in the field and could also face implementation headwinds.
Feb 05, 2016 at 15:16 | Source: Moneycontrol.com
Aarti Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 05, 2016, has declared 2nd Interim Dividend at Rs 1.50 (15 percent) per share for the financial year 2015-2016.
Feb 05, 2016 at 10:30 | Source: CNBC-TV18
The US governments decision to not allow overseas pharmaceutical companies to import active pharmaceutical ingredient (API) applies to only one particular anti retroviral drug and is not a blanket ban, Biocon CMD Kiran Mazumdar-Shaw said.
Messages on Drug Company »

sikandar

Gold Member

15 Followers

Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member

29 Followers

Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014

superwoman

Platinum Member

162 Followers

Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014

shakira9

New Member

3 Followers

Legal  

Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014

Raj_2009

Platinum Member

46 Followers

GlaxoSmithKline  

, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014

OrthoDoc

New Member

21 Followers

Aurobindo Pharm  

...so buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member

334653 Followers

Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014

tubes

Platinum Member

106 Followers

Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014

bhagyodayat
rust

Gold Member

21 Followers

Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member

334653 Followers

Cipla  

Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.